50 results on '"Vzorov AN"'
Search Results
2. Role of the long cytoplasmic domain of the SIV Env glycoprotein in early and late stages of infection
3. Prevention of poxvirus infection by tetrapyrroles
4. Modification of the Spike Protein for Vaccines against Enveloped RNA Viruses
5. Requirements for the Induction of Broadly Neutralizing Antibodies against HIV-1 by Vaccination
6. “Cytoplasmic domain effects on exposure of co-receptor-binding sites of HIV-1 Env”
7. VLP vaccines and effects of HIV-1 Env protein modifications on their antigenic properties
8. Immunogenicity of virus-like particles containing modified human immunodeficiency virus envelope proteins
9. Parameters of inhibition of HIV-1 infection by small anionic microbicides
10. Sulfonated naphthyl porphyrins as agents against HIV-1
11. Prevention of HIV-1 infection by platinum triazines
12. Prevention of HIV-1 infection by phthalocyanines
13. Virus-like particle and DNA-based candidate AIDS vaccines
14. Development of a rubella virus DNA vaccine
15. Investigation of the rigidity of housing parts and bushings of the cylinders of tractor diesels
16. Raising the corrosion resistance and corrosion-fatigue strength of screw propellers made of brass LMtsZh 55-3-1 by cathodic polarization
17. New designs for sanitary ware
18. Surface Stability and Immunogenicity of the Human Immunodeficiency Virus Envelope Glycoprotein: Role of the Cytoplasmic Domain
19. Effects of modification of the HIV-1 Env cytoplasmic tail on immunogenicity of VLP vaccines.
20. Effects of Stabilization of the gp41 Cytoplasmic Domain on Fusion Activity and Infectivity of SIVmac239.
21. Role of the long cytoplasmic domain of the SIV Env glycoprotein in early and late stages of infection.
22. Multiple domains of the SIV Env protein determine virus replication efficiency and neutralization sensitivity
23. Prevention of poxvirus infection by tetrapyrroles.
24. Effects of modification of the HIV-1 Env cytoplasmic tail on immunogenicity of VLP vaccines
25. Multiple domains of the SIV Env protein determine virus replication efficiency and neutralization sensitivity
26. Raising the corrosion resistance and corrosion-fatigue strength of screw propellers made of brass LMtsZh 55-3-1 by cathodic polarization.
27. Magnetic analysis of the reactions $pp \to np\Pi^{+}$ (I), $pp \to pp\Pi^{0}$ (II) and $pp \to d\Pi^{+}$ (III) at an energy of 660 Mev
28. Charged pion production by 660 Mev protons on beryllium and carbon
29. Energy spectra of $\pi^{+}$ mesons in the $pp -> np\pi^{+}$ reaction at 556 and 657 Mev
30. A search for the knockout of deuterons from carbon nuclei by 4.3 GeV/c protons.
31. Fragmentation of 6.3 GeV/c deuterons on h,d,c,al, and bi nuclei.
32. Elastic and quasielastic d-d scattering at 4.3, 6.3 and 8.9 GeV/c.
33. Fragmentation of 9 GeV/ c deuterons in the region of proton transverse momenta of 0.5–1 GeV/ c and the deuteron wave function at small distances
34. Assembly and Release of SIV Env Proteins with Full-Length or Truncated Cytoplasmic Domains
35. Nuclear interactions of 660 MeV protons and the momentum distribution of nucleons in nuclei
36. Engineering T-Cell Resistance to HIV-1 Infection via Knock-In of Peptides from the Heptad Repeat 2 Domain of gp41
37. Surface Stability and Immunogenicity of the Human Immunodeficiency Virus Envelope Glycoprotein: Role of the Cytoplasmic Domain.
38. Enhancement of immunogenicity of an HIV Env DNA vaccine by mutation of the Tyr-based endocytosis motif in the cytoplasmic domain
39. Enhanced Mucosal Immune Responses to HIV Virus-Like Particles Containing a Membrane-Anchored Adjuvant
40. Angular dependence of the cross section for the (. pi. /sup +/, No. 2p) in lithium nuclei at energy 85 +- 4 MeV
41. Incorporation of Glycosylphosphatidylinositol-Anchored Granulocyte- Macrophage Colony-Stimulating Factor or CD40 Ligand Enhances Immunogenicity of Chimeric Simian Immunodeficiency Virus-Like Particles.
42. An amphipathic sequence in the cytoplasmic tail of HIV-1 Env alters cell tropism and modulates viral receptor specificity.
43. Effects of stabilization of the gp41 cytoplasmic domain on fusion activity and infectivity of SIVmac239.
44. Enhanced mucosal immune responses to HIV virus-like particles containing a membrane-anchored adjuvant.
45. Inactivation of human immunodeficiency virus type 1 by porphyrins.
46. Effect of the cytoplasmic domain of the simian immunodeficiency virus envelope protein on incorporation of heterologous envelope proteins and sensitivity to neutralization.
47. Induction of immune responses to SIV antigens by mucosally administered vaccines.
48. Immunogenicity of full length and truncated SIV envelope proteins.
49. Highly immunogenic human immunodeficiency viruslike particles are produced by recombinant vaccinia virus-infected cells.
50. Intracellular localization of recombinant vaccinia virus produced HIV antigens and their use for confirmation of HIV seropositivity.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.